Literature DB >> 18647139

Current and emerging surrogate markers of hepatic fibrosis in primary biliary cirrhosis.

Jayant A Talwalkar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18647139      PMCID： PMC2561257          DOI： 10.1111/j.1478-3231.2008.01761.x

Source DB:  PubMed          Journal:  Liver Int        ISSN： 1478-3223            Impact factor:   5.828


× No keyword cloud information.
  17 in total

1.  Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis.

Authors:  Renée Eugénie Poupon; Keith D Lindor; Albert Parés; Olivier Chazouillères; Raoul Poupon; E Jenny Heathcote
Journal:  J Hepatol       Date:  2003-07       Impact factor: 25.083

2.  Evidence of angiogenesis in primary biliary cirrhosis: an immunohistochemical descriptive study.

Authors:  Jesús Medina; Paloma Sanz-Cameno; Luisa García-Buey; Samuel Martín-Vílchez; Manuel López-Cabrera; Ricardo Moreno-Otero
Journal:  J Hepatol       Date:  2005-01       Impact factor: 25.083

3.  Accuracy of staging in primary biliary cirrhosis.

Authors:  M C Garrido; S G Hubscher
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

4.  Serum hyaluronate in primary biliary cirrhosis--a biochemical marker for progressive liver damage.

Authors:  A Nyberg; A Engström-Laurent; L Lööf
Journal:  Hepatology       Date:  1988 Jan-Feb       Impact factor: 17.425

5.  Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression.

Authors:  C Degott; E S Zafrani; P Callard; B Balkau; R E Poupon; R Poupon
Journal:  Hepatology       Date:  1999-04       Impact factor: 17.425

6.  Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients.

Authors:  Christophe Corpechot; Fabrice Carrat; Raoul Poupon; Renee-Eugenie Poupon
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

Review 7.  Primary biliary cirrhosis.

Authors:  Jayant A Talwalkar; Keith D Lindor
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

8.  When is liver biopsy needed in the diagnosis of primary biliary cirrhosis?

Authors:  Claudia O Zein; Paul Angulo; Keith D Lindor
Journal:  Clin Gastroenterol Hepatol       Date:  2003-03       Impact factor: 11.382

9.  Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.

Authors:  Christophe Corpechot; Armelle Poujol-Robert; Dominique Wendum; Marie Galotte; Yves Chrétien; Renée Eugénie Poupon; Raoul Poupon
Journal:  Liver Int       Date:  2004-06       Impact factor: 5.828

10.  Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C.

Authors:  J Guéchot; R E Poupon; P Giral; B Balkau; J Giboudeau; R Poupon
Journal:  J Hepatol       Date:  1994-03       Impact factor: 25.083
View more
  2 in total

Review 1.  Review of pharmacotherapeutic treatments for primary sclerosing cholangitis.

Authors:  Chaoran Zhang; Trana Hussaini; Eric M Yoshida
Journal:  Can Liver J       Date:  2019-08-27

Review 2.  Natural history and management of primary biliary cirrhosis.

Authors:  Nadya Al-Harthy; Teru Kumagi
Journal:  Hepat Med       Date:  2012-12-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.